semaglutide & tirzepatide riverhead vs semaglutide: A new battle in obesity treatment Tirzepatide versus Semaglutide for Obesity

Wegovy commonly causes nausea, vomiting, and diarrhoea, particularly during the initial weeks of treatment

The challenge historically has been that pure glucagon agonism worsens glycemia

Key Takeaway: Facial gauntness and sagging skin are not caused by the medication itself, but are secondary effects of the body losing subcutaneous fat faster than the skin can adjust

If weight loss plateaus or appetite has returned to baseline, your provider may increase your dose at the next scheduled adjustment

Spread your calorie intake across three balanced meals rather than skipping meals, which can drop your energy precipitously

The VA is looking for veterans between the ages of 18 and 80 for the study